Strategic licensing transaction focuses on advancing a novel vaccine candidate for mastitis, one of the most challenging endemic diseases affecting dairy herds

 

Leverkusen, Germany, and Quebec, Canada, May 30, 2016 – Bayer and TransferTech Sherbrooke, the corporate entity responsible for commercializing the innovations emerging from the Université de Sherbrooke and its affiliated institutions, have signed a global license agreement to advance a novel vaccine candidate discovered at Université de Sherbrooke in Quebec, Canada, to help protect dairy cattle from mastitis caused by the bacterium Staphylococcus aureus.

More at: http://press.bayer.com/baynews/baynews.nsf/id/Bayer-Universit-Sherbrooke-Enter-License-Agreement-Drive-Innovation-Dairy-Cattle-Health?Open&parent=news-overview-category-search-en&ccm=020

Comments are closed.